United States · FDA National Drug Code directory
Visipaque
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0407-2223_3bf8b69f-3b64-4112-b08a-53bbf6dd57e8
- Product NDC
- 0407-2223
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Iodixanol
- Labeler
- GE Healthcare Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20030909
- Source listing expiry
- 20261231
Source-listed ingredients
- IODIXANOL — 320 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BOTTLE, PLASTIC in 1 BOX (0407-2223-16) / 50 mL in 1 BOTTLE, PLASTIC · 0407-2223-16
- 10 BOTTLE, PLASTIC in 1 BOX (0407-2223-17) / 100 mL in 1 BOTTLE, PLASTIC · 0407-2223-17
- 10 BOTTLE, PLASTIC in 1 BOX (0407-2223-19) / 150 mL in 1 BOTTLE, PLASTIC · 0407-2223-19
- 10 BOTTLE, PLASTIC in 1 BOX (0407-2223-21) / 200 mL in 1 BOTTLE, PLASTIC · 0407-2223-21
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →